• UTP Solution: Precision in RNA Synthesis and Metabolic Assay

  2026-05-20

  UTP Solution (100 mM) empowers RNA transcription, amplification, and metabolic research with unmatched purity—maximizing sensitivity and reproducibility even in DNase/RNase-sensitive settings. This APExBIO reagent unlocks advanced workflows, from single-cell epigenetic studies to high-throughput siRNA synthesis, with clear troubleshooting pathways for superior results.

• Gramine Induces Ferroptosis via CUL3–MTDH Axis in TNBC Model

  2026-05-19

  The referenced study uncovers how Gramine, a natural indole alkaloid, inhibits triple-negative breast cancer (TNBC) growth by inducing ferroptosis through direct modulation of the CUL3–MTDH ubiquitination pathway. This mechanistic insight positions Gramine as a promising research tool for dissecting ferroptosis and ubiquitination dynamics in aggressive cancer subtypes.

• Ruxolitinib Phosphate Triggers Apoptosis and Pyroptosis in A

  2026-05-19

  This study demonstrates that Ruxolitinib phosphate (INCB018424) induces both apoptosis and GSDME-mediated pyroptosis in anaplastic thyroid carcinoma (ATC) by inhibiting DRP1-mediated mitochondrial fission through JAK1/2-STAT3 pathway suppression. The findings provide new mechanistic insight into JAK/STAT signaling pathway modulation and highlight a potential therapeutic direction for aggressive thyroid cancers.

• Tamoxifen as a Selective Estrogen Receptor Modulator: Advanc

  2026-05-18

  Tamoxifen, a selective estrogen receptor modulator, is indispensable in gene knockout and cancer biology research. This article unpacks protocol refinements, troubleshooting, and the pivotal impact of recent findings on dose-dependent developmental effects, guiding researchers toward reproducible, high-fidelity results.

• Tofacitinib Reverses GM-CSF-Induced Mitochondrial Dysfunctio

  2026-05-18

  This article examines how tofacitinib (CP-690550) uniquely reverses inflammation and mitochondrial dysregulation in GM-CSF-reprogrammed macrophages from rheumatoid arthritis (RA) patients. By selectively inhibiting JAK/STAT signaling—particularly STAT5—this approach corrects metabolic and phenotypic abnormalities not addressed by anti-TNF, anti-IL6R, or metabolic-targeted therapies, highlighting new directions for immune modulation research.

• Stiripentol as an LDH Inhibitor: Metabolic Epigenetics in Fo

  2026-05-17

  Explore Stiripentol's role as a novel LDH inhibitor in metabolic epigenetics and advanced epilepsy research. This article uniquely connects lactate metabolism, histone lactylation, and experimental protocols for breakthrough insights.

• Degarelix Acetate: Potent GnRH Receptor Antagonist for Prost

  2026-05-16

  Degarelix acetate is a highly selective GnRH receptor antagonist approved for advanced prostate cancer. It delivers rapid, sustained suppression of pituitary hormones and serum testosterone, making it a benchmark tool in hormone secretion inhibition research. Clinical and preclinical data confirm its efficacy, specificity, and safety profile.

• Tetracycline in Precision Ribosome Assays: Mechanistic Depth

  2026-05-15

  Explore how Tetracycline, a broad-spectrum polyketide antibiotic, empowers advanced ribosomal function research. This in-depth article provides unique mechanistic analysis, protocol insights, and new guidance for optimizing microbiological experiments.

• 4-Hydroxytamoxifen: Technical Protocols for Laboratory Resea

  2026-05-15

  4-Hydroxytamoxifen (SKU B6167) is a high-purity estrogen receptor modulator optimized for controlled studies in breast cancer, prostate cancer, and cardiac myocyte research. It solves solubility and reproducibility issues commonly encountered in aqueous or ethanol-based workflows by providing reliable DMSO compatibility. Use is not recommended in protocols requiring water or ethanol solubility.

• CDK4 Regulates 4E-BP1 to Drive Cap-Dependent Translation in

  2026-05-14

  This study reveals cyclin-dependent kinase 4 (CDK4) as a direct regulator of the translational repressor 4E-BP1, facilitating cap-dependent translation during the mitosis–G1 transition. The findings provide new mechanistic insight into cell cycle-dependent translational control and have implications for understanding drug resistance and targeted cancer therapy.

• Mitochondrial Permeability Transition Pore Assay Kit: Applie

  2026-05-14

  Unlock sensitive and reproducible mitochondrial permeability assays with the APExBIO Mitochondrial Permeability Transition Pore Assay Kit. Explore advanced workflows, troubleshooting strategies, and translational insights drawn from cutting-edge research in cell death and mitochondrial dysfunction.

• Tofacitinib (CP-690550) Workflows for Immune Modulation Rese

  2026-05-13

  Tofacitinib (CP-690550) enables precise inhibition of JAK/STAT signaling, uniquely reversing GM-CSF-driven inflammation and mitochondrial dysfunction in immune cell models. This article translates cutting-edge findings into actionable protocols, troubleshooting guidance, and comparative advantages for advanced immune modulation research.

• Methotrexate as a Folate Antagonist: Applied Research Workfl

  2026-05-13

  Methotrexate’s versatility as a folate antagonist empowers robust research into immunosuppression, apoptosis, and anti-inflammatory mechanisms. This guide delivers actionable protocols, advanced troubleshooting, and comparative insights for maximizing reproducibility with APExBIO’s validated Methotrexate.

• Bright Light Triggers Lasting Anxiety via ipRGC–CeA Circuitr

  2026-05-12

  Wang et al. elucidate how brief acute bright light exposure in mice produces a sustained anxiogenic effect, mediated by melanopsin-expressing retinal ganglion cells (ipRGCs) projecting to the central amygdala. This research advances understanding of non-image forming visual circuits in mood regulation and provides chemogenetic circuit-mapping strategies for neuroscience.

• SB 202190: Applied Protocols for p38 MAP Kinase Inhibition

  2026-05-12

  SB 202190, a highly selective p38 MAP kinase inhibitor, enables precise dissection of MAPK signaling in inflammation and cancer models. This article translates new organoid-based research and best practices into actionable workflows, troubleshooting, and advanced use-cases for researchers.

14779 records 1/986 page Next 12345 下5页 Last page